Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Virol ; 92(7)2018 04 01.
Article in English | MEDLINE | ID: mdl-29343574

ABSTRACT

Human polyomavirus (HPyV) DNA genomes contain three regions denoted the early viral gene region (EVGR), encoding the regulatory T-antigens and one microRNA, the late viral gene region (LVGR), encoding the structural Vp capsid proteins, and the noncoding control region (NCCR). The NCCR harbors the origin of viral genome replication and bidirectional promoter/enhancer functions governing EVGR and LVGR expression on opposite DNA strands. Despite principal similarities, HPyV NCCRs differ in length, sequence, and architecture. To functionally compare HPyV NCCRs, sequences from human isolates were inserted into a bidirectional reporter vector using dsRed2 for EVGR expression and green fluorescent protein (GFP) for LVGR expression. Transfecting HPyV NCCR reporter vectors into human embryonic kidney 293 (HEK293) cells and flow cytometry normalized to archetype BKPyV NCCR revealed a hierarchy of EVGR expression levels with MCPyV, HPyV12, and STLPyV NCCRs conferring stronger levels and HPyV6, HPyV9, and HPyV10 NCCRs weaker levels, while LVGR expression was less variable and showed comparable activity levels. Transfection of HEK293T cells expressing simian virus 40 (SV40) large T antigen (LTag) increased EVGR expression for most HPyV NCCRs, which correlated with the number of LTag-binding sites (Spearman's r, 0.625; P < 0.05) and decreased following SV40 LTag small interfering RNA (siRNA) knockdown. LTag-dependent activation was specifically confirmed for two different MCPyV NCCRs in 293MCT cells expressing the cognate MCPyV LTag. HPyV NCCR expression in different cell lines derived from skin (A375), cervix (HeLaNT), lung (A549), brain (Hs683), and colon (SW480) demonstrated that host cell properties significantly modulate the baseline HPyV NCCR activity, which partly synergized with SV40 LTag expression. Clinically occurring NCCR sequence rearrangements of HPyV7 PITT-1 and -2 and HPyV9 UF1 were found to increase EVGR expression compared to the respective HPyV archetype, but this was partly host cell type specific.IMPORTANCE HPyV NCCRs integrate essential viral functions with respect to host cell specificity, persistence, viral replication, and disease. Here, we show that HPyV NCCRs not only differ in sequence length, number, and position of LTag- and common transcription factor-binding sites but also confer differences in bidirectional viral gene expression. Importantly, EVGR reporter expression was significantly modulated by LTag expression and by host cell properties. Clinical sequence variants of HPyV7 and HPyV9 NCCRs containing deletions and insertions were associated with increased EVGR expression, similar to BKPyV and JCPyV rearrangements, emphasizing that HPyV NCCR sequences are major determinants not only of host cell tropism but also of pathogenicity. These results will help to define secondary HPyV cell tropism beyond HPyV surface receptors, to identify key viral and host factors shaping the viral life cycle, and to develop preclinical models of HPyV persistence and replication and suitable antiviral targets.


Subject(s)
Antigens, Viral, Tumor , Gene Expression Regulation, Viral , Gene Rearrangement , Genome, Viral , Models, Genetic , Polyomaviridae , Antigens, Viral, Tumor/genetics , Antigens, Viral, Tumor/metabolism , HEK293 Cells , Humans , MicroRNAs/biosynthesis , MicroRNAs/genetics , Polyomaviridae/genetics , Polyomaviridae/metabolism , RNA, Viral/biosynthesis , RNA, Viral/genetics
2.
Curr Opin Virol ; 7: 73-8, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24983512

ABSTRACT

Multiple glycans have been identified as potential cell surface binding motifs for polyomaviruses (PyVs) using both crystallographic structural determinations and in vitro binding assays. However, binding alone does not necessarily imply that a glycan is a functional receptor, and confirmation that specific glycans are important for infection has proved challenging. In vivo analysis of murine polyomavirus (MPyV) infection has shown that subtle alterations in PyV-glycan interactions alone can result in dramatic changes in pathogenicity, implying that similar effects will be found for other PyVs. Our discussion will review the assays used for determining virus-glycan binding, and how these relate to known PyV tropism and pathogenesis.


Subject(s)
Polyomaviridae/metabolism , Polyomavirus Infections/metabolism , Polysaccharides/metabolism , Receptors, Virus/metabolism , Animals , Humans , Polyomaviridae/genetics , Polyomavirus Infections/virology , Viral Proteins/genetics , Viral Proteins/metabolism
3.
Food Environ Virol ; 6(4): 260-8, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24952878

ABSTRACT

Disinfection by low-pressure monochromatic ultraviolet (UVC) radiation (253.7 nm) became an important technique to sanitize drinking water and also wastewater in tertiary treatments. In order to prevent the transmission of waterborne viral diseases, the analysis of the disinfection kinetics and the quantification of infectious viral pathogens and indicators are highly relevant and need to be addressed. The families Adenoviridae and Polyomaviridae comprise human and animal pathogenic viruses that have been also proposed as indicators of fecal contamination in water and as Microbial Source Tracking tools. While it has been previously suggested that dsDNA viruses may be highly resistant to UVC radiation compared to other viruses or bacteria, no information is available on the stability of polyomavirus toward UV irradiation. Here, the inactivation of dsDNA (HAdV2 and JCPyV) and ssRNA (MS2 bacteriophage) viruses was analyzed at increasing UVC fluences. A minor decay of 2-logs was achieved for both infectious JC polyomaviruses (JCPyV) and human adenoviruses 2 (HAdV2) exposed to a UVC fluence of 1,400 J/m(2), while a decay of 4-log was observed for MS2 bacteriophages (ssRNA). The present study reveals the high UVC resistance of dsDNA viruses, and the UV fluences needed to efficiently inactivate JCPyV and HAdV2 are predicted. Furthermore, we show that in conjunction with appropriate mathematical models, qPCR data may be used to accurately estimate virus infectivity.


Subject(s)
Adenoviridae/radiation effects , DNA, Viral/radiation effects , Disinfection/methods , Polyomaviridae/radiation effects , RNA, Viral/radiation effects , Adenoviridae/metabolism , Adenoviridae/pathogenicity , Adenoviridae/ultrastructure , Adenoviruses, Human/metabolism , Adenoviruses, Human/pathogenicity , Adenoviruses, Human/radiation effects , Adenoviruses, Human/ultrastructure , Cell Line , DNA, Viral/metabolism , Humans , JC Virus/metabolism , JC Virus/pathogenicity , JC Virus/radiation effects , JC Virus/ultrastructure , Kinetics , Levivirus/metabolism , Levivirus/pathogenicity , Levivirus/radiation effects , Levivirus/ultrastructure , Microbial Viability/radiation effects , Microscopy, Electron, Transmission , Polyomaviridae/metabolism , Polyomaviridae/pathogenicity , Polyomaviridae/ultrastructure , RNA Stability/radiation effects , RNA, Viral/metabolism , Radiation Tolerance , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Ultraviolet Rays , Virion/metabolism , Virion/pathogenicity , Virion/radiation effects , Virion/ultrastructure , Virus Inactivation/radiation effects
4.
Virology ; 432(2): 316-26, 2012 Oct 25.
Article in English | MEDLINE | ID: mdl-22726243

ABSTRACT

Polyomaviruses are naked viruses with an icosahedral capsid that surrounds a circular double-stranded DNA molecule of about 5000 base-pairs. Their genome encodes at least five proteins: large and small tumor antigens and the capsid proteins VP1, VP2 and VP3. The tumor antigens are expressed during early stages of the viral life cycle and are implicated in the regulation of viral transcription and DNA replication, while the capsid proteins are produced later during infection. Members of the Polyomaviridae family have been isolated in birds (Avipolyomavirus) and mammals (Orthopolyomavirus and Wukipolyomavirus). Some mammalian polyomaviruses encode an additional protein, referred to as agnoprotein, which is a relatively small polypeptide that exerts multiple functions. This review discusses the structure, post-translational modifications, and functions of agnoprotein, and speculates why not all polyomaviruses express this protein.


Subject(s)
Carnivora/virology , Polyomaviridae/metabolism , Primates/virology , Rodentia/virology , Viral Regulatory and Accessory Proteins/metabolism , Amino Acid Sequence , Animals , Humans , Molecular Sequence Data , Polyomaviridae/genetics , Polyomaviridae/isolation & purification , Protein Processing, Post-Translational , Subcellular Fractions/metabolism , Viral Regulatory and Accessory Proteins/chemistry , Viral Regulatory and Accessory Proteins/genetics
5.
Curr Opin Mol Ther ; 5(5): 524-8, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14601522

ABSTRACT

A major challenge in the field of gene therapy is the development of new carrier/delivery systems that lack the disadvantages of current transfer systems. In the past, some time has been spent developing such modified or alternative vectors. A new candidate is represented by virus-like particles (VLPs). It has been shown that recombinant expression of the major structural proteins of many viruses leads to the formation of VLPs. Such VLPs exhibit morphology similar to the empty capsids of the virus from which they are derived. VLPs are non-infectious, have a similar tropism to the natural virus, and show comparable cellular uptake and intracellular trafficking. Since its discovery, VLP technology has gained importance in biomedical research. Although most investigations into VLP technology have dealt with vaccine development, some research groups have demonstrated that VLPs could also represent a useful gene therapy delivery system. This review will focus on studies performed with VLPs from members of the Papillomaviridae and Polyomaviridae families.


Subject(s)
Gene Transfer Techniques , Genetic Therapy , Genetic Vectors/metabolism , Virion/genetics , Animals , DNA, Viral/metabolism , Genetic Vectors/genetics , Genetic Vectors/immunology , Humans , Papillomaviridae/genetics , Papillomaviridae/metabolism , Polyomaviridae/genetics , Polyomaviridae/metabolism , Virion/immunology , Virion/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...